• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎与肠易激病的相关性:一项系统评价

The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review.

作者信息

Alhaj Zachrieh, Almubaid Zaid, Kleto Gengi, Ahmad Nabeel, Rojas Vivian, Pinto-Cuberos Juan, Munoz Gonzalez Ayezel

机构信息

Messrs. Alhaj and Almubaid are with the John Sealy School of Medicine at the University of Texas Medical Branch in Galveston, Texas and the Department of Internal Medicine at the University of Texas Medical Branch in Galveston, Texas.

Ms. Kleto is with the John Sealy School of Medicine at the University of Texas Medical Branch in Galveston, Texas and the Department of Dermatology at the University of Texas Medical Branch in Galveston, Texas.

出版信息

J Clin Aesthet Dermatol. 2025 May 1;18(5):20-25.

PMID:40538531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12175838/
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is an inflammatory skin condition that presents with nodules or abscesses associated with sinus tracts. Inflammatory bowel diseases (IBD) are inflammatory gastrointestinal (GI) conditions presenting with irregular bowel movements. Although HS and IBDs may have similarities in their clinical presentation and pathophysiology, they can differ in their cutaneous manifestations. Both conditions are potentially caused by genetic changes in the human leukocyte antigen (HLA), cause skin inflammation, and are characterized by abscesses in the GI and sinus tracts.

OBJECTIVE

We sought to determine the extent of coincident IBD and HS and the associated risk factors.

METHODS

The Ovid Medline database was searched for all current literature on the correlations between HS and IBD. Articles were then included and removed according to specific inclusion and exclusion criteria, and a systematic review was performed on the remaining articles.

RESULTS

Thirteen papers that met the inclusion and the exclusion criteria were selected, and after data collection, a significant correlation was found between the development of HS and IBD. Most of the articles reviewed stated that the corresponding association was a causal link between the two diseases. Furthermore, there were various risk factors and comorbidities associated with HS and the development of IBD, including smoking, obesity, perianal disease, and genetic predispositions such as HLA-B27 mutations.

DISCUSSION

Studies show that there is a potential correlation with HS and IBDs. Additional research should to determine the genetic correlations between HS and IBDs and the underlying pathophysiological mechanism.

摘要

背景

化脓性汗腺炎(HS)是一种炎症性皮肤病,表现为与窦道相关的结节或脓肿。炎症性肠病(IBD)是炎症性胃肠道疾病,表现为排便不规律。尽管HS和IBD在临床表现和病理生理学上可能有相似之处,但它们的皮肤表现可能不同。这两种疾病都可能由人类白细胞抗原(HLA)的基因变化引起,都会导致皮肤炎症,并且都以胃肠道和窦道中的脓肿为特征。

目的

我们试图确定IBD与HS同时存在的程度以及相关危险因素。

方法

在Ovid Medline数据库中搜索关于HS与IBD相关性的所有现有文献。然后根据特定的纳入和排除标准纳入和剔除文章,并对其余文章进行系统评价。

结果

选择了13篇符合纳入和排除标准的论文,在收集数据后,发现HS与IBD的发生之间存在显著相关性。大多数综述文章指出,相应的关联是这两种疾病之间的因果联系。此外,与HS和IBD的发生相关的危险因素和合并症有多种,包括吸烟、肥胖、肛周疾病以及诸如HLA - B27突变等遗传易感性。

讨论

研究表明HS与IBD之间存在潜在相关性。应进行更多研究以确定HS与IBD之间的遗传相关性以及潜在的病理生理机制。

相似文献

1
The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review.化脓性汗腺炎与肠易激病的相关性:一项系统评价
J Clin Aesthet Dermatol. 2025 May 1;18(5):20-25.
2
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
5
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.
6
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.白细胞介素(IL)-17A和IL-17F在化脓性汗腺炎发病机制中的作用:来自人体体外临床前实验和临床样本的证据
Br J Dermatol. 2025 Mar 18;192(4):660-671. doi: 10.1093/bjd/ljae442.
7
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Obesity and novel management of inflammatory bowel disease.肥胖与炎症性肠病的新治疗策略。
World J Gastroenterol. 2023 Mar 28;29(12):1779-1794. doi: 10.3748/wjg.v29.i12.1779.
2
Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.炎症性肠病与化脓性汗腺炎之间的因果关联:两样本双向孟德尔随机化研究。
Front Immunol. 2023 Jan 26;14:1071616. doi: 10.3389/fimmu.2023.1071616. eCollection 2023.
3
Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.一项巢式病例对照研究中的化脓性汗腺炎与炎症性肠病
Dig Liver Dis. 2023 Apr;55(4):490-495. doi: 10.1016/j.dld.2022.10.016. Epub 2022 Nov 9.
4
Effect of smoking on the development and outcomes of inflammatory bowel disease in Taiwan: a hospital-based cohort study.吸烟对台湾炎症性肠病发展和结局的影响:一项基于医院的队列研究。
Sci Rep. 2022 May 10;12(1):7665. doi: 10.1038/s41598-022-11860-y.
5
Association of hidradenitis suppurativa with autoimmune disease and autoantibodies.化脓性汗腺炎与自身免疫性疾病及自身抗体的关联。
Rheumatol Adv Pract. 2021 Dec 27;6(2):rkab108. doi: 10.1093/rap/rkab108. eCollection 2022.
6
Risk Factors for Developing Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Retrospective Case-Control Study.炎症性肠病患者发生化脓性汗腺炎的危险因素:一项回顾性病例对照研究。
J Can Assoc Gastroenterol. 2020 Jul 28;4(4):165-172. doi: 10.1093/jcag/gwaa024. eCollection 2021 Aug.
7
The Association among Pyoderma Gangrenosum, Ulcerative Colitis, and Hidradenitis Suppurativa and the Syndromic Hidradenitis Suppurativa Network: A Case Report.坏疽性脓皮病、溃疡性结肠炎和化脓性汗腺炎之间的关联以及化脓性汗腺炎综合征网络:一例报告
Skin Appendage Disord. 2021 Apr;7(3):227-230. doi: 10.1159/000513639. Epub 2021 Mar 4.
8
The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study.皮肤表现与炎症性肠病之间的时间关系及关联:一项基于全国人群的队列研究
J Clin Med. 2021 Mar 22;10(6):1311. doi: 10.3390/jcm10061311.
9
Adherent-invasive Escherichia coli (AIEC): Cause or consequence of inflammation, dysbiosis, and rupture of cellular joints in patients with IBD?黏附侵袭性大肠杆菌(AIEC):是 IBD 患者炎症、菌群失调和细胞连接破裂的原因还是结果?
J Cell Physiol. 2020 Jun;235(6):5041-5049. doi: 10.1002/jcp.29430. Epub 2020 Jan 3.
10
Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.化脓性汗腺炎:将炎症途径整合到一个连贯的致病模型中的系统评价。
Front Immunol. 2018 Dec 14;9:2965. doi: 10.3389/fimmu.2018.02965. eCollection 2018.